Total submissions: 1
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Gene |
RCV000421437 | SCV000534720 | likely pathogenic | not provided | 2016-12-28 | criteria provided, single submitter | clinical testing | The G1182C variant in the COL5A2 gene has not been reported previously as a pathogenic variant, nor as a benign variant, to our knowledge. The G1182C variant was not observed in approximately 6500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The G1182C variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position that is conserved across species. In silico analysis predicts this variant is probably damaging to the protein structure/function. As an alternate mechanism, multiple in silico algorithms predict that this sequence change might strengthen a cryptic splice acceptor site within exon 50, which may supplant the natural splice acceptor site of intron 49. However, in the absence of RNA/functional studies, the actual effect of this sequence change in this individual is unknown. The G1182C variant is a strong candidate for a pathogenic variant, however, the possibility it may be a rare benign variant cannot be excluded. |